利多卡因
医学
麻醉
口腔粘膜
局部麻醉
局部麻醉剂
牙科
药理学
病理
作者
Hyunkyu Lee,Hye Su Min,Mingyu Jang,Geonwoo Kang,Seongdae Gong,Chisong Lee,Young Woo Song,Ui‐Won Jung,Somin Lee,Hyeon Yeol Ryu,Huisuk Yang,Hyungil Jung
标识
DOI:10.1080/17425247.2023.2216450
摘要
Background Lidocaine has been widely used as a short-acting local anesthetic agent to reduce the pain caused by needle insertion. Dissolving microneedles (DMNs), which are minimally invasive, can effectively deliver drugs by overcoming the oral mucosal barrier and relieving patient discomfort.Methods Lidocaine solution prepared by mixing lidocaine-HCl and hyaluronic acid was used to fabricate oral lidocaine HCl-encapsulated DMNs (oral Li-DMNs) via centrifugal lithography. The dissolution, penetration ability, and local transmucosal drug delivery of oral Li-DMNs into the oral mucosa were evaluated in porcine jaws. Pharmacokinetic analysis and safety assessment were performed using rabbits.Results The insertion depth of the oral Li-DMNs satisfies the safety standard. The oral Li-DMNs were completely dissolved after 3 min of application. The local transmucosal drug delivery, pharmacokinetic, and safety evaluations showed that the oral Li-DMNs can obtain a local anesthesia effect at a relatively lower dose, and there was no oral mucosal irritation in rabbits.Conclusions A novel and safe oral Li-DMNs have potential applications in large animals and clinical trials and would possibly enter the anesthesia market.
科研通智能强力驱动
Strongly Powered by AbleSci AI